US2010292502A1PendingUtilityA1
Method for preparing high-purity fesoterodine fumarate
Est. expiryMay 15, 2029(~2.8 yrs left)· nominal 20-yr term from priority
C07C 59/40C07C 227/16C07C 219/28
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A process is described for preparing fesoterodine fumarate comprising the salification reaction of fesoterodine with fumaric acid in an organic solvent, preferably a ketone, at a temperature not greater than 45° C. Such process allows obtaining products with high yields and purities, and in particular a product having a content of (2E)-4-[(3-(3-diisopropylamino-1-phenylpropyl)-4-(2-isobutyroyloxyphenyl)methoxy]-4-oxobut-2-enoic acid less than or equal to 0.15% by mole.
Claims
exact text as granted — not AI-modified1 . Process for preparing fesoterodine fumarate comprising reacting fesoterodine with fumaric acid, wherein said reaction step is carried out in at least one organic solvent at a temperature not higher than 45° C.
2 . Process according to claim 1 , wherein said temperature is comprised between 30 and 40° C.
3 . Process according to claim 2 , wherein said temperature is about 35° C.
4 . Process according to claim 1 , further comprising heating a mixture of fesoterodine and fumaric acid in said at least one organic solvent until complete dissolution, and cooling the solution thus obtained at a temperature lower than 25° C.
5 . Process according to claim 4 , wherein said heating step is carried out for a period comprised between 10 minutes and two hours.
6 . Process according to claim 5 , wherein said heating step is carried out for a period comprised between 30 minutes and one hour.
7 . Process according to claim 4 , wherein said cooling step is carried out at a temperature comprised between 5 and 20° C.
8 . Process according to claim 7 , wherein said cooling step is carried out at a temperature comprised between 15 and 20° C.
9 . Process according to claim 1 , wherein said at least one organic solvent is a polar aprotic organic solvent.
10 . Process according to claim 1 , wherein said at least one organic solvent is a ketone.
11 . Process according to claim 10 , wherein said ketone has from three to six carbon atoms.
12 . Process according to claim 10 , wherein said ketone is methylethylketone.
13 . Process according to claim 1 , wherein said fumaric acid is used in molar ratios comprised between 0.9 and 1.5 with respect to fesoterodine.
14 . Process according to claim 13 , wherein said fumaric acid is used in molar ratios comprised between 1.0 and 1.1 with respect to fesoterodine.
15 . Process according to claim 1 , wherein said fesoterodine is used in a weight/volume ratio comprised between 2 and 50 with respect to said at least one organic solvent.
16 . Process according to claim 15 , wherein said fesoterodine is used in a weight/volume ratio comprised between 3 and 10 with respect to said at least one organic solvent.
17 . Process according to claim 1 , wherein the fesoterodine fumarate thus obtained is filtered, washed, dried under vacuum and/or micronized.
18 . Process according to claim 17 , wherein the fesoterodine fumarate is micronized until obtaining a PSD with d (0.9)≦20 micron.
19 . Fesoterodine fumarate having a content of (2E)-4-[(3-(3-diisopropylamino-1-phenylpropyl)-4-(2-isobutyroyloxyphenyl)methoxy]-4-oxobut-2-enoic acid less than or equal to 0.15% by mole.
20 . Micronized fesoterodine fumarate having a content of (2E)-4-[(3-(3-diisopropylamino-1-phenylpropyl)-4-(2-isobutyroyloxyphenyl)methoxy]-4-oxobut-2-enoic acid less than or equal to 0.15% by mole and a PSD with d (0.9)≦20 micron.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.